• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMX
Click for more information
0.00% 0.0¢

INTERSTAR MILLENNIUM SERIES 2003-3G TRUST

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMX
Ann: IMS 2003-3G Rate Reset (A3&B2) 27 Mar 2019 		27/03/19 0 39
27/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  39 
IMX
Ann: IMS 2003-3G Rate Reset (A2&B1) 27 Mar 2019 		27/03/19 0 35
27/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  35 
IMX
Ann: IMS 2003-3G Bond Factor 27 Mar 2019 		27/03/19 0 46
27/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  46 
IMX
Ann: IMS 2003-3G Rate Reset (A3&B2) 27 Dec 2018 		27/12/18 0 138
27/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  138 
IMX
Ann: IMS 2003-3G Rate Reset (A2&B1) 27 Dec 2018 		27/12/18 0 140
27/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  140 
IMX
Ann: IMS 2003-3G Financial Report 30 June 2018 		01/10/18 0 110
01/10/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  110 
IMX
Ann: IMS 2003-3G Rate Reset A3 & B2 27 Sept 2018 		01/10/18 0 92
01/10/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  92 
IMX
Ann: IMS 2003-3G Rate Reset (A2 & B1) 27 Sep 18 		01/10/18 0 93
01/10/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  93 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.